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Background. Cholesterol accumulates in renal cortical proxi-
mal tubules in response to diverse forms of injury or physiologic
stress. However, the fate of triglycerides after acute renal insults
is poorly defined. This study sought new insights into this issue.
Methods. CD-1 mice were subjected to three diverse models
of renal stress: (1) endotoxemia [Escherichia coli lipopolysac-
charide (LPS), injection]; (2) ischemia/reperfusion (I/R); or (3)
glycerol-induced rhabdomyolysis. Renal cortical, or isolated
proximal tubule, triglyceride levels were measured ∼18 hours
later. To gain mechanistic insights, triglyceride levels were de-
termined in (1) proximal tubules following exogenous phos-
pholipase A2 (PLA2) treatment; (2) cultured HK-2 cells after
mitochondrial blockade (antimycin A) ± serum; or (3) HK-2
cells following “septic” (post-LPS) serum, or exogenous fatty
acid (oleate) addition.
Results. Each form of in vivo injury evoked three-to four-
fold triglyceride increases in renal cortex and/or proximal
tubules. PLA2 treatment of proximal tubules evoked acute,
dose-dependent, triglyceride formation. HK-2 cell triglyceride
levels rose with antimycin A. With serum present, antimycin
A induced an exaggerated triglyceride loading state (vs. serum
alone or antimycin A alone). “Septic” serum stimulated HK-
2 triglyceride formation (compared to control serum). Oleate
addition caused striking HK-2 cell triglyceride accumulation.
Following oleate washout, HK-2 cells were sensitized to adeno-
sine triphosphate (ATP) depletion or oxidant attack.
Conclusion. Diverse forms of renal injury induce dramatic
triglyceride loading in proximal tubules/renal cortex, suggest-
ing that this is a component of a cell stress response. PLA2
activity, increased triglyceride/triglyceride substrate (e.g., fatty
acid) uptake, and possible systemic cytokine (e.g., from LPS)
stimulation, may each contribute to this result. Finally, in ad-
dition to being a marker of prior cell injury, accumulation of
triglyceride (or of its constituent fatty acids) may predispose
tubules to superimposed ATP depletion or oxidant attack.
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In recent years, it has become increasingly apparent
that renal cortical cholesterol accumulation is a delayed
consequence of diverse forms of kidney damage. For ex-
ample, within 18 to 24 hours of ischemic, toxic, obstruc-
tive, or immunologic insults, ∼30% and ∼300% increases
in renal cortical/proximal tubular free cholesterol and
cholesteryl ester levels result, respectively [1–8]. Physi-
ologic stress (e.g., heat shock, endotoxemia, hyperosmo-
lality) can also trigger renal cholesterol accumulation in
the absence of tubular cell death [5]. This strongly sug-
gests that renal cholesterol accumulation is not simply
a “downstream” consequence of severe tissue damage.
Rather, it more likely represents an integral component
of a generic tissue “stress response.” Much remains to
be discerned concerning mechanisms by which cell stress
evokes a cholesterol loading state. However, available
data indicate that multiple pathways, including increased
cholesterol synthesis/cell uptake, and decreased cell ef-
flux, may each contribute, and in a disease-specific fashion
[5–8]. Given the protean effects of membrane cholesterol
on cell homeostasis, the “downstream” pathophysiologic
consequences of postinjury cholesterol loading remains
incompletely defined. However, one result is decreased
tubular cell susceptibility to further attack [1–3, 7]. This
phenomenon has been denoted by the terms “cytoresis-
tance” and “acquired resistance to acute renal failure”
[9, 10].
Unlike cholesterol, the fate of renal cortical triglyc-
eride content following acute renal damage remains
largely unknown. Given that triglyceride is the major cel-
lular neutral lipid, the question emerges as to whether
altered triglyceride expression develops following renal
injury, and analogous to cholesterol, is it a component
of the renal “stress response?” Indeed, a few pieces
of support for this concept exist. In 1983, Tannenbaum
et al reported that by 24 hours postinduction of unilat-
eral ureteral obstruction (UUO), increased renal cor-
tical/medullary triglyceride content resulted [11]. That
triglycerides were also modestly elevated in the contralat-
eral kidney suggests that physiologic stress (e.g., in this
case, compensation for nephron loss), in addition to struc-
tural injury, might also trigger a triglyceride loading state.
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In another study, Venkatachalam et al [12] found that 5
hours of mitochondrial blockade in LLC-PK1 cells in-
duced by antimycin A caused modest triglyceride eleva-
tions. However, the converse did not appear to be the case
in vivo. Triglyceride levels fell, rather than rose, 1 hour
postinduction of renal ischemia/reperfusion (IR) damage
[13]. Thus, the fate of triglycerides following renal injury
remains obscure.
Given these considerations, the present study was
undertaken to ascertain whether triglycerides, like
cholesterol, accumulate in response to renal injury or
physiologic stress. If so, such findings would help place
the previous findings of Tannenbaum, Purkerson, and
Klahr [11] and Venkatachalam et al [12] into a broader
pathophysiologic context. Therefore, the impacts of three
highly diverse forms of in vivo renal injury/physiologic
stress (renal ischemia; heme protein nephrotoxicity; en-
dotoxemia) on renal cortical and/or proximal tubular
triglyceride content were assessed. To gain initial mech-
anistic insights, additional experiments were performed
using either isolated mouse proximal tubule segments or
cultured proximal tubular (HK-2) cells subjected to dif-
ferent forms of stress. The results of these studies form
the basis of this report.
METHODS
General methods
Male CD-1 mice (25 to 35 g) (Charles River Labo-
ratories, Wilmington, MA, USA) were used for all in
vivo experiments. They were maintained under routine
vivarium conditions until experimentation and allowed
free food and water access. The mice were sacrificed for
blood and/or tissue sampling under deep pentobarbital
anesthesia (∼2 to 4 mg intraperitoneally). The abdomi-
nal cavity was opened via a midline abdominal incision.
Blood samples were withdrawn from the inferior vena
cava (IVC) using heparinized or nonheparinized syringes
for obtaining either plasma or serum, respectively. Imme-
diately post phlebotomy, the kidneys were resected, iced,
and used for subsequent lipid analyses, as denoted below.
Purified endotoxin injection: Effects on renal cortical
cholesterol and triglyceride levels
It has previously been demonstrated that administra-
tion of heat killed Escherichia coli induces renal choles-
terol loading [5, 7]. This experiment assessed whether
purified endotoxin [lipopolysaccharide (LPS)] injection
can reproduce these E. coli-induced cholesterol incre-
ments (as opposed to other bacterial components), and
to determine whether there are corresponding changes
in triglyceride levels. Twelve unanesthetized mice were
individually placed into loose cylindric restraints and in-
jected via the tail vein with either 0, 5, or 10 mg/kg of
purified E. coli LPS (0111:B4; L-2630) (Sigma Chemical
Co., St. Louis, MO, USA) (stock solution, 4 mg/mL saline)
(N = 4 per treatment). The controls (no LPS) received
LPS vehicle injection (0.1 mL saline intravenously). Fol-
lowing the injections, the mice were allowed free food
and water access. Approximately 18 hours later, they
were anesthetized with pentobarbital, a blood sample
was withdrawn from the IVC [for blood urea nitrogen
(BUN) analysis by autoanalyzer technology] (Beckman
Coulter, Fullerton, CA, USA). The kidneys were then
promptly resected, as noted above. Cortical tissue sam-
ples underwent lipid extraction in chloroform: methanol,
and the chloroform-recovered lipids were assayed for
free cholesterol and cholesteryl ester content by gas chro-
matography (GC) [3] and for triglyceride (see below).
Tissue triglyceride, free cholesterol, and cholesteryl ester
results were expressed as nmol/lmol phospholipid phos-
phate (Pi) [3].
Triglyceride analysis was performed on plasma and on
renal cortical lipid extracts [3] using a commercially avail-
able enzymatic assay (#2780-400H) (Thermo Electron,
Arlington, TX, USA). This method utilizes a lipase to
deacylate tissue triglycerides following their recovery in
the chloroform extraction phase. The generated free glyc-
erol was then assayed. Of note, any endogenous free glyc-
erol which might exist in tissue prior to tissue extraction
is not measured by this assay because free glycerol en-
ters the methanol, not the chloroform (lipid) extraction
phase (confirmed in this laboratory by testing spiked glyc-
erol additions). It is possible that mono- and diglycerides
could also be detected by this assay, following deacyla-
tion to glycerol. However, preliminary studies using a
lipid affinity column (BondElut NH2) (Varian, Harbor
City, CA, USA), which separates triglycerides from other
glycerol containing moieties confirmed that 85% to 95%
of the tissue triglyceride reactants reflected true triglyc-
eride content (higher percentages in injured vs. control
tissues; as would be expected with a triglyceride loading
state). Hence, the values were taken as triglyceride levels.
Effect of LPS injection on isolated tubule triglyceride,
cholesterol, and injury responses
By 18 to 24 hours postinjection of heat-killed E. coli,
proximal tubular cells manifest “cytoresistance” to either
hypoxic or oxidative injury, as assessed in isolated prox-
imal tubule segments [9]. The following experiment was
conducted to (1) ascertain whether purified LPS injection
elicits this same cytoprotective response; and (2) to de-
termine corresponding triglyceride and cholesterol lev-
els directly at the proximal tubular cell level. Eight mice
were subjected to either 10 mg/kg LPS or LPS vehicle
injection (N = 4 each). Eighteen hours later, the kidneys
were removed, iced, and cortical proximal tubular seg-
ments were prepared by collagenase digestion, sieving,
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and Percoll centrifugation [14]. The recovered tubules
from each mouse were divided into three equal aliquots
(∼2 mg proximal tubular protein/mL of experimenta-
tion buffer) [14], and rewarmed over 15 minutes from
isolation temperature (4◦C) to 37◦C. The aliquots from
each mouse were then subjected to one of the following
incubations: (1) control incubation × 20 minutes (95%
O2/5% CO2); (2) 10 minutes of hypoxic incubation (95%
N2/5% CO2); or (3) incubation × 20 minutes with an
oxidant insult [ferrous ammonium sulfate complexed to
the siderophore hydroxyquinoline (FeHQ), 25 lmol/L
of each] [15]. At the completion of the incubations, cell
injury was assessed by% tubule lactate dehydrogenase
(LDH) release [14]. Those tubules which had been sub-
jected to control incubation conditions were extracted
in chloroform: methanol and used for free cholesterol,
cholesteryl ester, and triglyceride analysis (N = 4 pairs of
samples from control and post-LPS–treated mice). Lipid
results were expressed as nmol/lmol Pi.
Renal cortical triglyceride levels following I/R injury
By 18 to 24 hours post in vivo I/R, renal cortical choles-
terol increments result [1]. The following experiment
assessed whether this form of injury also alters renal
triglyceride levels. Three mice were anesthetized with
pentobarbital, subjected to right nephrectomy through
a midline laparotomy, and then the left renal vascular
pedicle was occluded × 15 minutes with an atraumatic
vascular clamp. Body temperature was maintained at
∼37◦C with a heating lamp. Following vascular clamp re-
moval and restitution of blood flow, the abdominal inci-
sion was sutured with two layers of 4-0 chromic sutures.
The mice were allowed to recover from anesthesia with
free food and water access. Approximately 18 hours later,
they were reanesthetized, the abdominal incisions were
opened, and blood was obtained for BUN and triglyc-
eride analysis. The postischemic kidneys were resected,
lipid extracts prepared, and assayed for triglyceride con-
tent.
Three groups of control mice were established for the
above experiment. These included (1) four normal kid-
neys resected from mice without prior interventions; (2)
three mice subjected to sham surgery without ischemia or
uninephrectomy; and (3) three mice subjected to unilat-
eral (right) nephrectomy followed by left renal resection
18 hours later. Renal cortex was then assayed for triglyc-
eride content.
Effect of rhabdomyolysis on renal cortical triglyceride
levels
To further assess the impact of renal injury on triglyc-
eride levels, a third model of acute renal failure was
chosen: glycerol-induced rhabdomyolysis [4, 10]. Six
mice were briefly anesthetized with isoflurane and then
injected with either 8, 8.5, or 9.0 mL/kg of 50% glycerol
(N = 2 at each dose; glycerol administered intramuscu-
larly in divided doses into both upper hind limbs). Six
mice, briefly anesthetized with isoflurane, served as con-
trols. Eighteen hours later, the mice were anesthetized
with pentobarbital, plasma was obtained (for BUN and
triglyceride determination), and then the kidneys were
removed to assess renal cortical triglyceride levels. The
latter were correlated with both the glycerol dosage
and the severity of BUN elevations. [Note: Since exoge-
nous glycerol could potentially provide the “backbone”
for triglyceride synthesis (following its phosphorylation
to glycerol-3-phosphate), correlations between glycerol
dosage, triglyceride levels, and severity of injury, were
assessed. However, exogenously administered glycerol
would not directly alter the triglyceride assay, since any
free glycerol would not enter the chloroform phase dur-
ing lipid extraction, as noted above.]
Impact of acute cell injury on isolated tubule
triglyceride levels
The following two sets of experiments were undertaken
to gain possible insights into mechanisms by which tubu-
lar injury might evoke triglyceride increments.
Impact of phospholipase A2 (PLA2) on tubular cell
triglyceride levels. Four sets of isolated tubules were pre-
pared from four normal mice and divided into four equal
aliquots: aliquot 1, control incubation for 30 minutes;
aliquots 2 to 4, incubation with bovine pancreatic PLA2
(P8913) (Sigma Chemical Co.), in dosages of either 5, 10,
or 25 U/mL. At the end of the incubations,% LDH release
was determined, the tubule suspensions were extracted
in chloroform:methanol, and assayed for triglyceride con-
tent.
Impact of hypoxia/reoxygenation and iron-mediated
oxidative stress. Four sets of tubules were prepared and
divided into the following six aliquots: 1 and 2, control
incubation × 20 minutes ± 2 mmol/L glycine; aliquots 3
and 4, incubation with ferrous ammonium sulfate, com-
plexed with equimolar amounts of the siderophore hy-
droxyquinoline (FeHQ ± 2 mmol/L glycine) to induce
oxidative stress [15]; and aliquots 5 and 6, 10 minutes of
hypoxic incubation (95% N2/5% CO2) + 10 minutes of
reoxygenation (95% O2/5% CO2) ± 2 mmol/L glycine.
At the completion of the incubations,% LDH release was
assessed, followed by triglyceride analysis. [Note: Glycine
was added to half the incubations to mitigate lethal cell
injury, such that triglyceride levels could be assessed in
the presence/absence of cell death [16].]
Cultured proximal tubular (HK-2) cell experiments
Impact of “septic serum.” The following experiment
was undertaken to ascertain whether serum from sep-
tic mice (containing inflammatory cytokines) would alter
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tubular cell triglyceride content. If so, this would help
to dissociate LPS-mediated in vivo tubular cell triglyc-
eride changes from possible LPS-derived renal hemody-
namic effects. Six T-25 Costar flasks were seeded with
HK-2 proximal tubular cells in keratinocyte serum-free
medium (K-SFM), as previously described [17]. After
reaching near confluence in 2 days, they were divided
into two treatment groups: (1) addition of 12.5% control
serum (obtained from normal pentobarbital anesthetized
mice; followed by complement heat inactivation at
56◦C × 30 minutes); and (2) addition of 12.5% “septic”
serum (obtained from three mice 2 hours after 10 mg/kg
LPS injection; heat inactivated, as above). The cells were
incubated under routine culture conditions for 18 hours
and then the media was removed and saved for triglyc-
eride analysis (to assess the amount of triglyceride ex-
posure resulting from serum addition). The flasks were
iced and washed × 3 with Hanks balanced salt solution
(+Ca/Mg). The cells were detached with a cell scraper, re-
covered by centrifugation, the lipids extracted in chloro-
form:methanol, and the extracts assayed for triglyceride
content, as noted above.
Mitochondrial inhibition with antimycin A: Impact on
HK-2 cell triglyceride levels. When HK-2 cells are sub-
jected to mitochondrial electron chain inhibition, largely
sublethal cell injury results, due to partial support of
adenosine triphosphate (ATP) levels by glycolysis [18].
The following experiment assessed the impact of this form
of cell injury on triglyceride levels. Twenty T-75 costar
flasks of HK-2 cells, cultured over 2 to 3 days to near
confluence, were divided into four experimental groups
(N = 5 per group) as follows: (1) control incubation; (2)
incubation with 7.5 lmol/L antimycin A (in 0.1% ethanol
final concentration); (3) incubation with 5% heat inac-
tivated mouse serum (Gemini Bioproducts, Woodland,
CA, USA); and (4) incubation with 5% mouse serum +
antimycin A. After completing 18-hour incubations un-
der these conditions, the cells were washed, recovered,
the lipids extracted, and assayed for triglyceride content.
The antimycin A challenges were conducted in the ab-
sence vs. the presence of serum in an attempt to dissociate
de novo triglyceride synthesis (serum absent) vs. possible
triglyceride/fatty acid uptake (serum present).
Effect of “septic” serum and antimycin A treatments
on cell viability (LDH release). To assess the impact of
the above treatments on HK-2 cell viability, two 24-well
Costar plates were seeded with HK-2 cells, as follows: (1)
control incubation; (2) incubation with 12.5% heat inac-
tivated septic serum; (3) incubation with 12.5% control
heat inactivated serum; (4) incubation with 7.5 lmol/L
antimycin A; (5) incubation with 5% normal heat inacti-
vated mouse serum (Gemini Bioproducts); and (6) incu-
bation with 5% heat inactivated serum + antimycin A.
After 18 hours,% LDH release was determined. In order
to make this determination, the amount of LDH in the
serum which was added to the culture medium (i.e., ex-
ogenously added LDH) was subtracted from the media
LDH content after completing each of the challenges.
Effect of fatty acid supplementation on HK-2 cell triglyc-
eride content. The following experiment was undertaken
to test whether exogenous fatty acid supplementation
leads to an increase in HK-2 cell triglyceride content.
Sixteen T-75 flasks were seeded with HK-2 cells. After
achieving near confluence (2 days), they were divided
into four groups (four flasks each): group 1, 5% fatty acid
free bovine serum albumin (BSA) addition; or groups
2 to 4, BSA with either 0.25 mmol/L, 0.5 mmol/L, or
1 mmol/L oleic acid (O-1008) (Sigma Chemical Co.) ad-
dition. After 18-hour incubations, the cells were washed
with Hanks solution and harvested for triglyceride anal-
ysis.% LDH release was also determined.
Fatty acid−mediated TG loading: Effect on cellular re-
sistance to superimposed attack. The following experi-
ment was undertaken to ascertain whether triglyceride
loading, like cholesterol loading, induces a cytoresistant
state. To this end, six 24-well Costar plates were divided
into the following treatment groups: group 1, incuba-
tion with 5% BSA; group 2, incubation with BSA +
0.5 mmol/L oleate; and group 3, incubation with BSA
+ 1 mmol/L oleate. After 18-hour incubations, the plates
were washed using normal culture medium (K-SFM) to
remove the BSA and fatty acid additions. Next, the cells
were subjected to one of the following treatments: (1)
control incubations × 18 hours; (2) ATP depletion/Ca2+
ionophore addition (“CAD” challenge = 7.5 lmol/L
calcium ionophore A23187 + 7.5 lmol/L antimycin A +
20 mmol/L 2-deoxyglucose); or (3) oxidant injury (10 lM
FeHQ). After completing the challenges, cell injury was
assessed by% LDH release. [Thus, these experiments al-
lowed assessment of the effects of two oleate doses (with
resulting two degrees of triglyceride loading; see Results
section) on HK-2 cell susceptibility to two forms of su-
perimposed attack (CAD or FeHQ).]
Calculations and statistics
All values are presented as means ± 1 SEM. Statistical
comparisons were made by paired or unpaired Student
t testing. If multiple comparisons were made, the Bonfer-
roni correction was applied. Significance was judged by a
P value of < 0.05.
RESULTS
LPS injection effects on renal cortical cholesterol
and triglyceride levels
As shown in Figure 1, left panel, the 5 and 10 mg/kg
LPS injections induced ∼15% and 22% increases in re-
nal cortical free cholesterol content, respectively. LPS
induced even greater% increases in cholesteryl esters,
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Fig. 1. Renal cortical free cholesterol (FC), cholesteryl esters (CE), and triglyceride (TG) levels 18 hours following endotoxin [lipopolysaccharide
(LPS)] injection. LPS exposure caused significant, dose-dependent, increases in both free cholesterol and cholesteryl esters (left and middle
panels). As shown in the right panel, quantitatively more dramatic, and dose-dependent, increases in renal cortical triglyceride accumulation
occurred following LPS injection.
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Fig. 2. Lipopolysaccharide (LPS) injection induces proximal tubu-
lar cytoresistance. Isolated proximal tubules were extracted from ei-
ther LPS-exposed, or control mice and then tested for cytoresistance
(response to either hypoxia or FeHQ-mediated oxidative stress). As
shown, the post-LPS-exposed tubules manifested significant reductions
in lactate dehydrogenase (LDH) release with either the hypoxic or iron
(Fe) challenge, indicating that cytoresistance was present.
rising ∼500% and ∼600% with the 5 and 10 mg/kg LPS
doses (Fig. 1, middle panel). [Thus, these results indi-
cate that previously documented renal cortical choles-
terol increments following heat killed E. coli injection [5,
7] arose as a consequence of LPS exposure, rather than
as a response to alternative bacterial components (e.g.,
proteases).]
LPS also induced dramatic, dose-dependent, increases
in renal cortical triglyceride concentrations (Fig. 1, right
panel). At the higher LPS dose, an approximate 400%
triglyceride increase was apparent, rising from ∼7 to
∼30 nmol/lmol Pi.
LPS induced dose-dependent azotemia (BUN concen-
trations 29 ± 2, 60 ± 15, and 94 ± 20 mg/dL with 0, 5,
and 10 mg/kg LPS injections, respectively) (P < 0.015,
10 mg/kg vs. controls). Plasma cholesterol levels were not
significantly impacted by LPS injection (120 ± 15; 138 ±
10; and 132±20 mg/dL for 0, 5, and 10 mg/kg LPS dosages,
respectively). Conversely, plasma triglyceride levels were
elevated at 18 hours post-LPS injection (289 ± 7 mg/dL
vs. controls, 92 ± 20 mg/dL) (P < 0.01).
LPS effects on proximal tubular resistance to
superimposed injury
As shown in Figure 2, proximal tubules isolated from
mice treated 18 hours earlier with 10 mg/kg LPS man-
ifested the cytoresistance phenomenon [1, 7]. This was
denoted by almost complete protection against hypoxic
injury (NS vs. control incubations), and by a 35% reduc-
tion in iron-mediated % LDH release. (Thus, these results
indicate that prior observations of tubule cytoresistance
following heat-killed E. coli injection [7] can be recapit-
ulated with purified E. coli LPS treatment.)
LPS effects on isolated tubule cholesterol and
triglyceride levels
The tubules from the above experiments which un-
derwent control incubations were subjected to free
cholesterol, cholesteryl esters, and triglyceride analyses.
Significantly higher values for each were observed in the
tubules harvested from the LPS-treated vs. control mice
(see Fig. 3).
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Fig. 3. Quantitation of free cholesterol (FC), cholesteryl esters (CE), or triglycerides (TG) in isolated proximal tubules harvested from either
control (cont) mice or mice which were 18 hours postlipopolysaccharide (LPS) injection. The tubules obtained from the post-LPS-treated mice
showed significant free cholesterol, cholesteryl esters, and triglyceride increases. The latter were by far the greatest, as assessed on a molar basis
(∼100 nmol/lmol increase for triglyceride vs. ∼35 and ∼5 nmol/lmol increase for free cholesterol and cholesteryl esters, respectively).
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Fig. 4. Triglyceride (TG) levels in renal
cortex from normal mice, mice subjected
to renal ischemia/reperfusion (I/R), unilat-
eral nephrectomy (UniNx), or sham surgery
(sham) (left panel). By 18 hours post-I/R,
triglyceride levels had increased ∼fourfold in
renal cortex. This could not be explained by
either contralateral nephrectomy or by the
stress of surgery, as neither of these controls
had elevated triglyceride levels, compared to
normal mouse kidney cortex. Right panel,
triglyceride levels in renal cortex 18 hours
postglycerol-induced rhabdomyolysis, com-
pared to controls. Rhabdomyolysis evoked
∼3× increases in renal cortical triglyceride
levels, compared to matched controls.
Effect of renal ischemia on renal cortical
triglyceride levels
Renal ischemia + 18 hours of reflow, performed on
uninephrectomized mice, caused an approximate fivefold
increase in renal cortical triglyceride levels (Fig. 4) (P <
0.0001). This increase could not be attributed to either to
the stress of surgery or to the effects of unilateral nephrec-
tomy because neither sham surgery nor uninephrec-
tomy significantly altered renal cortical triglyceride levels
(Fig. 4). Postischemic terminal plasma triglyceride values
were markedly reduced at the time of renal triglyceride
analysis (controls, 92 ± 13 mg/dL; postischemia, 39 ±
1 mg/dL) (P < 0.02). [Thus, the higher renal cortical
triglyceride levels in the postischemic kidney could not
simply be ascribed to potential blood-trapping effects.]
The BUNs for the three postischemic mice were 35, 56,
and 110 mg/dL (normal values <30 mg/dL). The degree
of azotemia in these three mice strongly correlated with
the corresponding degree of renal cortical triglyceride ac-
cumulation (32, 33, and 37 mg/dL, respectively; r, 0.99).
Effects of rhabdomyolysis-induced acute renal failure on
renal cortical triglyceride levels
As shown in Figure 4, right panel, glycerol-induced
rhabdomyolysis caused an approximate 3× increase in re-
nal cortical triglyceride levels, compared to sham-treated
controls. Glycerol injection also induced severe acute re-
nal failure (BUNs 152 ± 8 mg/dL; vs. controls, 28 ± 2 mg/
dL) (P < 0.001). The renal cortical triglyceride levels for
each mouse correlated much better with the severity of
azotemia which was observed in each animal (BUN range
128 to 184 mg/dL; r, 0.66 vs. cortical triglyceride level),
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Fig. 5. Effects of exogenous phospholipase
A2 (PLA2), iron-mediated oxidant injury
(FeHQ), and hypoxia/reoxygenation (H/R)
injury on triglyceride (TG) levels in iso-
lated mouse proximal tubules. Left panel,
PLA2 addition to isolated tubules caused
dose-dependent triglyceride increments.
Right panel, conversely, FeHQ-mediated
oxidant stress [ferrous ammonium sul-
fate/hydroxyquinoline (FeHQ)], significantly
decreased tubule triglyceride levels. H/R had
no discernible triglyceride effect.
than with the absolute dose of glycerol which each mouse
had received (r, −0.12). [This suggests that the triglyc-
eride accumulation was a reflection of the severity of in-
jury, rather than the exact dose of glycerol injected.]
Plasma triglyceride levels varied greatly in the glycerol-
treated mice (from 20 to 130 mg/dL; mean, 82 ± 35 mg/dL;
control values, 100 ± 8 mg/dL). These variations could
not be explained by the dose of glycerol which was ad-
ministered (dose vs. plasma triglyceride levels, r = 0.16).
However, when the plasma triglyceride values (square
roots) were contrasted with the prevailing renal cortical
triglyceride elevations, a strong inverse correlation was
observed (r, 0.80, P < 0.05) (i.e., the lower the plasma
triglyceride level, the greater the cortical triglyceride
content).
Isolated proximal tubule-acute injury experiments
PLA2 treatment. Incubating proximal tubules with
PLA2 caused dose-dependent increases in triglyceride
levels (see Fig. 5, left panel), each dose being statisti-
cally different from controls (P < 0.025). These changes
occurred without any lethal cell injury, as denoted by%
LDH release (controls, 11 ± 1%; PLA2, 11 ± 1%, 12 ±
1%, and 10 ± 1% for the 5, 10 and 25 U/mL PLA2 treat-
ments, respectively).
Iron-mediated oxidative stress. Iron treatment signifi-
cantly lowered, rather than raised, triglyceride levels by
∼25% (Fig. 5, right panel) whether or not the incuba-
tions were conducted with 2 mmol/L glycine to miti-
gate cell death. [Hence, for presentation, the ± glycine
triglyceride results are combined.]% LDH releases were
controls, 9 ± 1%; iron, 24 ± 2%; and iron + glycine 17 ±
1%.
Hypoxia/reoxygenation (H/R) injury. H/R did not al-
ter triglyceride levels, whether or not glycine was present
(for presentation, the triglyceride results are combined)
(Fig. 5, right panel). This was despite the fact that glycine
completely blocked H/R-induced cell death (LDH re-
lease controls, 9 ± 1%; H/R 23 ± 1%; and H/R + glycine
10 ± 1%). [Thus, in both the iron and H/R experiments,
triglyceride levels were not impacted by the extent of cell
death.]
Cultured HK-2 cell experiments
Septic serum exposure. Cells exposed to 12.5% septic
serum had an approximate 25% increase in triglyceride
content, compared to 12.5% serum-incubated controls
(415 ± 25 vs. 315 ± 10 nmol/lmol Pi, respectively) (P =
0.037) (not shown in figures). This difference could not be
explained by a difference in serum triglyceride content
(and hence cell triglyceride exposure following serum
addition), given that the 2-hour postseptic serum and
control mouse serum had comparable triglyceride con-
centrations (controls 165 ± 20; 2-hour septic serum 153 ±
1 mg/dL). [Note: This is different than the hypertriglyc-
eridemia which developed at 18 hours post-LPS injec-
tion, and hence it was the reason for harvesting serum
from LPS-treated mice prior to the development of high
serum triglyceride levels.] The septic serum exerted a mild
cytotoxic effect, raising% LDH release from 7.1 ± 0.2%
(control serum) to 10.5 ± 0.6% (P < 0.001).
Antimycin A/HK-2 cell experiments. As shown in
Figure 6, incubating HK-2 cells with antimycin A in
the absence of serum caused triglycerides to increase by
∼50 nmol/lmol Pi (P < 0.002). Exposing the cells to
5% serum alone (in absence of antimycin A) led to
marked HK-2 cell triglyceride increases (P < 0.001).
When antimycin A was added to serum-exposed cells, it
further raised triglyceride content by ∼120 nmol/lmol Pi.
When comparing the antimycin A-induced triglyceride
increases in the presence vs. the absence of serum, it is
apparent that the increase was approximately 2 12 times as
great (∼50 vs. 120 nmol/lmol Pi) when the antimycin A
challenge was conducted with serum present. Antimycin
A induced a minor degree of cell death in the absence
of serum (controls 4.9 ± 0.1%; antimycin A 8.2 ± 0.3%
LDH release) (P < 0.001), and in the presence of serum
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Fig. 6. Antimycin A (AA) effects on HK-2 cell triglyceride (TG) con-
tent in the absence or presence of 5% serum. Antimycin A caused
an approximate 50 nmol/lmol increase in triglyceride content when
the cells were maintained in serum-free medium (left two bars) (P
< 0.002), However, when serum was present, antimycin A caused a
125 nmol/lmol triglyceride increase, compared to their serum-matched
controls. This indicates that antimycin A was able to induce far more
triglyceride loading in the presence, vs. the absence, of serum. Serum
addition alone also raised triglyceride levels (vs. no serum) (P < 0.001),
indicating presumptive triglyceride uptake, or triglyceride substrate in-
corporation, into cellular triglyceride pools.
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Fig. 7. Effect of fatty acid (oleate) addition on HK-2 cell triglyceride
(TG) levels. Addition of increasing doses of oleate, added in the pres-
ence of 5% bovine serum albumin (BSA), caused dramatic, stepwise
increases in triglyceride content. All values were statistically different.
∗P < 0.001, compared to the controls (no oleate addition).
(serum alone 7.1 ± 0.2%; serum + antimycin A 10.5 ±
0.6% LDH release) (P < 0.005).
Oleic acid supplementation: Effect of HK-2 cell triglyc-
eride content. None of the oleic acid doses caused any
lethal cell injury, as assessed by LDH release (<3%
for all treatment groups). As shown in Figure 7, BSA-
treated HK-2 cells had a triglyceride level of 30 ±
6 nmol/lmol Pi. When oleate was added along with BSA,
a steep dose-response relationship with triglyceride levels
resulted (rising to 221 ± 25 nmol/lmol Pi) (P < 0.001).
Effects of oleic acid supplementation/triglyceride load-
ing on cell susceptibility to injury. As shown in Figure 8,
oleate treatment of HK-2 cells did not affect their vi-
ability under baseline conditions. However, when the
cells were pre-treated with oleate (followed by its
washout), it predisposed to both iron and ATP de-
pletion/calcium ionophore-induced cell death (Fig. 8).
This injury-sensitizing effect was dose dependent, being
greater with the 1 mmol/L vs. the 0.5 mmol/L oleate pre-
treatments (comparing results in the two Figure 8 panels).
DISCUSSION
As previously noted, UUO has been documented
to evoke significant triglyceride accumulation in renal
medulla, and to a lesser extent, in renal cortex [11]. How-
ever, whether these triglyceride increments were specific
for obstructive renal injury, or whether they were re-
flective of a more generalized renal injury response, was
not defined. The current investigations indicate that the
latter situation is almost certainly the case. This conclu-
sion is based on observations that three highly divergent
forms of in vivo renal injury, notably endotoxemia, I/R,
and rhabdomyolysis, each evoked striking, and compara-
ble, degrees of renal cortical triglyceride accumulation.
The results obtained with LPS injection are particularly
noteworthy. Unlike ureteral obstruction, I/R, or rhab-
domyolysis, each of which causes marked renal histologic
damage, endotoxemia induces a hemodynamic, or “pre-
renal,” form of acute renal failure [5]. Thus, that renal
triglyceride loading developed following LPS injection
indicates that structural renal injury is not a prerequi-
site for this response. Rather, when viewing all of the
available data together, it appears that triglyceride ac-
cumulation seemingly reflects a previously unrecognized
component of a generic renal “stress response” (i.e., anal-
ogous to an up-regulation of cholesterol levels). Indeed,
on a quantitative (molar) basis, triglycerides increase to a
much greater extent than does total cholesterol (∼300%
vs. ∼25% increases, respectively) in each form of injury
tested to date [1–8].
Given the heterogeneity of cell types within renal
cortex, the structures which account for, or participate
in, postinjury triglyceride accumulation cannot be as-
certained by whole tissue analysis. Therefore, to ascer-
tain whether proximal tubules are prominently involved,
they were isolated from LPS-treated and control mice
and triglyceride levels were assessed. As with renal cor-
tex, ∼3 to 4× higher triglyceride levels were observed
in post-LPS-exposed isolated tubules, compared to their
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Fig. 8. Impact of oleate-induced triglyceride loading on HK-2 cell susceptibility to superimposed oxidant or adenosine triphosphate (ATP) deple-
tion/calcium ionophore-induced attack. Cells were treated × 24 hours with either 0.5 or 1 mmol/L oleate/bovine serum albumin (BSA) to enhance
cell triglyceride levels. This was followed by cell washing to remove the oleate/BSA from the medium prior to the addition of the challenges (FeHQ
= ferrous ammonium sulfate/hydroxyquinoline complex; CAD = calcium ionophore A23187 + antimycin + 2-deoxyglucose). Both forms of injury
were intensified by prior oleate exposure/triglyceride supplementation. This injury-potentiating effect was oleate dose-dependent (> with 1 mmol/L
vs. 0.5 mmol/L oleate pretreatment).
matched isolated tubule controls. Of further note, abso-
lute triglyceride levels in both control and experimental
isolated tubules were ∼ twice as high, on a molar basis,
as their corresponding renal cortical tissue samples. This
suggests that the proximal tubule are relatively triglyc-
eride enriched, compared with other cortical structures. If
true, then the proximal tubule compartment, which com-
prises ∼70% of cortical mass, must account for the bulk of
postinjury triglyceride accumulation in renal cortex. Of
note, endotoxemia caused hypertriglyceridemia by the
time of tissue sampling (18 hours postinjection). How-
ever, that isolated (blood-free) tubules from LPS-treated
mice had three to four times higher triglyceride levels
than did control tubules indicates that possible plasma
triglyceride contamination of tissue samples cannot ex-
plain the higher cortical triglyceride levels. This point is
further underscored by the rhabdomyolysis and I/R in-
jury results. Plasma triglyceride levels were significantly
suppressed in these animals, and yet, three- to fourfold
renal cortical triglyceride elevations were observed.
Cellular triglyceride levels reflect a balance between
synthesis, substrate catabolism, and possible endocytic
transport across the plasma membrane [19–25]. The avail-
able data suggest that multiple mechanisms, rather than
any single pathway, likely account for the presently doc-
umented injury-induced renal triglyceride loading state.
The following possibilities appear particularly relevant in
this regard, based on the available data.
PLA2 activation with free fatty acid channeling
into triglycerides
It is well recognized that diverse forms of cell injury,
including those utilized in this study, activate PLA2 [26–
28]. This results in fatty acid mobilization from phos-
pholipid pools, presumably increasing their availability
for triglyceride formation via diacylglycerol acyltrans-
ferase (DGAT) activity. To prove that PLA2-mediated
free fatty acid mobilization can promote triglyceride for-
mation, we tested whether a nonlethal dose of exoge-
nous PLA2 might increase triglyceride content in isolated
tubules. As illustrated in Figure 5 (left panel), a tight
dose-response relationship between PLA2 dosage and
resulting tubule triglyceride levels was observed. Thus,
these new observations prove that PLA2 activity can, in-
deed, increase tubular triglyceride content. However, it
should also be noted that when endogenous PLA2 was
activated by either H/R or iron-induced oxidant stress,
no isolated tubule triglyceride increments resulted. This
indicates that other injury-induced pathways must mod-
ulate the extent to which PLA2 activity is able to en-
hance cellular triglyceride pools (e.g., possible loss of
DGAT activity). Indeed, this is consistent with previous
in vivo observations of Matthys et al [13]. These investi-
gators observed that renal cortical triglyceride levels did
not increase, but rather slightly decreased, immediately
post-I/R tissue damage. Thus, other factors must also be
involved.
Decreased mitochondrial consumption increases free
fatty acid availability
It is well known that renal tubular metabolic work de-
clines with reductions in glomerular filtration rate (GFR).
This is due to decreased sodium filtration, and hence,
decreased sodium reabsorption. For example, with se-
vere acute renal failure, renal O2 consumption falls by
∼80% [29]. Since free fatty acids are the dominant tubular
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mitochondrial substrate [30], it follows that a decrease in
tubular sodium reabsorption/metabolic work decreases
free fatty acid utilization, thereby increasing fatty acid
availability for possible triglyceride formation. Given
that endotoxemia, rhabdomyolysis, and I/R injury each
caused marked reductions in GFR (as denoted by
azotemia), a decrease in mitochondrial respiration, and
hence, fatty acid consumption/beta oxidation, would be
expected to provide additional free fatty acid for triglyc-
eride formation. Clearly, a reduction in GFR does not
pertain to the current in vitro (HK-2; isolated tubule) ex-
periments. However, it is noteworthy that both antimycin
A and PLA2 directly, and indirectly, decrease mito-
chondrial respiration [31], respectively. Thus, decreased
mitochondrial fatty acid utilization might well have con-
tributed to triglyceride accumulation even in the current
in vitro experiments.
Increased triglyceride/triglyceride substrate uptake from
the circulation
In the previously discussed study by Tannenbaum
et al [11], increased accumulation of intravenously
administered 14C14-labeled fatty acid (oleate, arachi-
donate) was observed in unilaterally obstructed kid-
neys. However, it could not be determined whether
these increased levels reflected increased uptake and/or
decreased fatty acid metabolism (e.g., due to a corre-
sponding near cessation of GFR). The present study
provides direct evidence supporting the notion that in-
creased triglyceride/triglyceride substrate uptake does,
in fact, contribute to an injury-evoked triglyceride ac-
cumulation state. When HK-2 cells were challenged with
antimycin A in the absence of serum, increased triglyc-
eride levels occurred. However, when this same protocol
was conducted in the presence of serum (with its con-
stituent triglycerides and fatty acids), exaggerated triglyc-
eride accumulation resulted (i.e., above that which could
be accounted for by either antimycin A alone, or serum
addition alone). Furthermore, when HK-2 cells were in-
cubated with increasing doses of oleic acid, dramatic,
dose-dependent, triglyceride formation resulted. Thus, it
appears that injured tubular cells can rapidly increase
their uptake of exogenous triglyceride/triglyceride sub-
strate (fatty acids), resulting in an enhancement of cel-
lular triglyceride pools. Whether cell injury causes an
increase in direct triglyceride endocytosis, or simply
triglyceride substrate (i.e., fatty acid) uptake, remains to
be defined. However, it is noteworthy that following both
in vivo I/R and rhabdomyolysis, a striking inverse cor-
relation was noted between circulating triglycerides and
renal cortical triglyceride content. This provides strong,
albeit indirect, support for the concept advanced above:
that circulating triglycerides (or their derived fatty acids)
may well contribute to an renal injury-evoked triglyceride
loading state. Finally, it appears that such processes may
be enhanced by circulating cytokines, given that serum
from septic mice caused far greater HK-2 cell triglyceride
accumulation than did control serum despite comparable
serum triglyceride levels.
The final issue which was addressed in this study was
whether postinjury triglyceride loading, or the processes
leading to it, might impact subsequent injury responses, or
the emergence of the previously discussed “cytoresistant
state.” To address this issue, cells were triglyceride loaded
via oleate treatment, and then the oleate was washed out
of the culture medium prior to the application of an oxi-
dant (iron) or ATP depletion challenge. The importance
of fatty acid washout prior to assessing susceptibility to
injury resides in the fact that unsaturated fatty acids can
exert selected cytoprotective effects [32–36]. Despite this
consideration, oleate-induced triglyceride supplementa-
tion induced striking, dose-dependent, increases in sus-
ceptibility to oxidant and ATP depletion-induced attack.
Given the complexity of fatty acid uptake and the “down-
stream” consequences thereof, it is impossible to con-
clude at this time that postinjury triglyceride loading,
per se, exerts a direct injury-provoking effect. For ex-
ample, free fatty acids can exert a variety of pronecrotic,
as well as apoptotic influences, mediated via direct mem-
brane lytic effects, alterations in pro- and antiapoptotic
proteins, mitochondrial cytochrome-c release, cytotoxic
ceramide generation, altered cell signaling (e.g., via pro-
tein kinase C) [35–38]. Thus, it is possible that direct ad-
verse oleate effects on cell homeostasis, rather than the
resulting triglyceride accumulation, was responsible for
the proinjury effect. Indeed, it has been speculated in
the literature that triglyceride formation may represent a
protective response, due to a shuttling cytotoxic fatty acids
into neutral lipid [35, 36]. On the other hand, it would
seem prudent to leave open the possibility that triglyc-
eride loading, per se, predisposes to cell injury, given that
oleate treatment, by itself, caused no overt HK-2 cytotoxi-
city, and because exogenous oleate was removed from the
cell culture medium following triglyceride loading. Thus,
although cellular “lipotoxicity” [35, 36] is generally con-
sidered a consequence of fatty acid toxicity rather than
the resulting triglyceride formation, the present data sug-
gest that the latter possibility may still exist. Indeed, if
true, then excess injury-induced triglyceride formation
could have a biphasic response: first, protecting against
cytotoxic fatty acid accumulation, and second, potential
delayed adverse effects, potentially mitigating a post in-
jury cytoresistant state. Whether or how cellular triglyc-
eride overload, per se, might impact cell injury responses
remains a largely unexplored issue at this time.
CONCLUSION
The present study demonstrates that diverse forms of
renal injury evoke dramatic triglyceride accumulation
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in renal cortex and in proximal tubular cells. That this
occurs with heterogeneous insults, and whether or not
structural renal damage results, suggest that triglyceride
accumulation is a previously unrecognized component
of the generic renal “stress response.” Multiple mecha-
nisms likely contribute to this triglyceride accumulation,
including excess PLA2 activity, cytokine stimulation, in-
creased triglyceride synthesis, and increased triglyceride
or triglyceride substrate (e.g., fatty acid) uptake. The
contribution(s) of each to triglyceride loading, and the
downstream consequences thereof, represent interesting
scientific issues which could have potentially important
implications for both cell injury and/or repair.
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